Moiseenko, Fedor https://orcid.org/0000-0003-2544-9042
Bogdanov, Alexey
Egorenkov, Vitaliy
Volkov, Nikita
Moiseyenko, Vladimir
Article History
Accepted: 6 September 2022
First Online: 21 October 2022
Declarations
:
: Fedor Moiseenko reports personal fees from Pfizer, personal fees and non-financial support from Astra Zeneca, personal fees from Takeda, personal fees and nonfinancial support from Biocad, personal fees from Novartis, personal fees from MSD, personal fees from Roche, personal fees from BMS, personal fees from Lilly, non-financial support from Boehringer Ingelheim, outside the submitted work. Alexey Bogdanov, Vitaliy Egorenkov, Nikita Volkov, and Vladimir Moiseyenko declare that they have no competing interests.
: This article does not contain any studies with human or animal subjects performed by any of the authors.